Shaughnessy Robinson received a B.S. in Chemistry from Wright State University, OH. He worked at Sterling Winthrop and Pfizer for many years doing synthetic and computational chemistry on a variety of small molecule drug discovery programs. He is currently employed by Schrödinger, Inc. in the Drug Discovery Applications Group.
Recent Advances in the Discovery of Small Molecule Inhibitors of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) as a Therapeutic Target for Inflammation and Oncology Disorders
† Nimbus Discovery, 25 First Street, Suite 404, Cambridge, Massachusetts 02141, United States
‡ Schrödinger Inc., 120 West Forty-Fifth Street, New York, New York 10036, United States
J. Med. Chem., 2015, 58 (1), pp 96–110